Daniel Clark
Stock Analyst at Leerink Partners
(2.81)
# 1,683
Out of 5,140 analysts
7
Total ratings
80%
Success rate
35.66%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Clark
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IDXX IDEXX Laboratories | Maintains: Outperform | $580 → $600 | $696.46 | -13.85% | 3 | Jul 17, 2025 | |
| ZTS Zoetis | Downgrades: Market Perform | $180 → $155 | $125.08 | +23.92% | 2 | Jul 17, 2025 | |
| ELAN Elanco Animal Health | Upgrades: Outperform | $18 | $24.30 | -25.93% | 2 | Jul 17, 2025 |
IDEXX Laboratories
Jul 17, 2025
Maintains: Outperform
Price Target: $580 → $600
Current: $696.46
Upside: -13.85%
Zoetis
Jul 17, 2025
Downgrades: Market Perform
Price Target: $180 → $155
Current: $125.08
Upside: +23.92%
Elanco Animal Health
Jul 17, 2025
Upgrades: Outperform
Price Target: $18
Current: $24.30
Upside: -25.93%